Ionis Pharmaceuticals IONS Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's interest paid?
- Ionis Pharmaceuticals (IONS) reported interest paid of $90K in Q1 2026.
- How has Ionis Pharmaceuticals's interest paid changed year-over-year?
- Ionis Pharmaceuticals's interest paid decreased by 2.2% year-over-year, from $92K to $90K.
- What is the long-term trend for Ionis Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's interest paid has grown at a 22.6% compound annual growth rate (CAGR), from $4.78M to $10.78M.
- What does interest paid mean?
- Cash spent on interest payments for debt.
- How do you interpret interest paid?
- Lower interest paid relative to total debt indicates efficient debt management or favorable borrowing terms.
- How does interest paid compare across companies?
- Standard supplemental cash flow disclosure for evaluating debt service costs.